Cargando…
Predicting In Vivo Anti-Hepatofibrotic Drug Efficacy Based on In Vitro High-Content Analysis
BACKGROUND/AIMS: Many anti-fibrotic drugs with high in vitro efficacies fail to produce significant effects in vivo. The aim of this work is to use a statistical approach to design a numerical predictor that correlates better with in vivo outcomes. METHODS: High-content analysis (HCA) was performed...
Autores principales: | Zheng, Baixue, Tan, Looling, Mo, Xuejun, Yu, Weimiao, Wang, Yan, Tucker-Kellogg, Lisa, Welsch, Roy E., So, Peter T. C., Yu, Hanry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206809/ https://www.ncbi.nlm.nih.gov/pubmed/22073152 http://dx.doi.org/10.1371/journal.pone.0026230 |
Ejemplares similares
-
Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids
por: Wu, Xiaoshan, et al.
Publicado: (2023) -
The Self-Limiting Dynamics of TGF-β Signaling In Silico and In Vitro, with Negative Feedback through PPM1A Upregulation
por: Wang, Junjie, et al.
Publicado: (2014) -
Computational analysis reveals the coupling between bistability and the sign of a feedback loop in a TGF-β1 activation model
por: Li, Huipeng, et al.
Publicado: (2017) -
Experimenting Liver Fibrosis Diagnostic by Two Photon Excitation Microscopy and Bag-of-Features Image Classification
por: Stanciu, Stefan G., et al.
Publicado: (2014) -
Deep learning enables automated scoring of liver fibrosis stages
por: Yu, Yang, et al.
Publicado: (2018)